Tech Company Financing Transactions

Presidio Pharmaceuticals Funding Round

Presidio Pharmaceuticals closed a $26 million Series B financing round on 8/29/2007. Investors included Panorama Capital, Baker Brothers Investments and Bay City Capital.

Transaction Overview

Company Name
Presidio Pharmaceuticals
Announced On
8/29/2007
Transaction Type
Venture Equity
Amount
$26,000,000
Round
Series B
Investors

Panorama Capital (Lead Investor) (Srinivas Akkaraju)

Baker Brothers Investments (Felix Baker)

Bay City Capital (Daniel Perez)

Nexus Medical Partners

Sagamore Ventures (Peter Brooks)

Ventures West (Kenneth Galbraith)

Proceeds Purpose
Dr. Omar K. Haffar, President and CEO of Presidio Pharmaceuticals said, "The proceeds of this financing will be used to advance two of our programs into human clinical studies, continue establishing alliances with outside partners, and expand our product portfolio through additional in-licensing transactions."

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1700 Owens St. 184
San Francisco, CA 94158
USA
Phone
(415) 655-7560
Website
www.presidiopharma.com
Email Address
[email protected]
Overview
Presidio is focused on developing novel and established therapeutic modalities and small molecule compounds for the treatment of HIV-1, HCV and other chronic virus infections.
Profile
Presidio Pharmaceuticals LinkedIn Company Profile
Social Media
Presidio Pharmaceuticals Company Twitter Account
Company News
Presidio Pharmaceuticals News
Facebook
Presidio Pharmaceuticals on Facebook
YouTube
Presidio Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Financial Officer
Leo Redmond
  Leo Redmond LinkedIn Profile  Leo Redmond Twitter Account  Leo Redmond News  Leo Redmond on Facebook
Chief Medical Officer
Nathaniel Brown
  Nathaniel Brown LinkedIn Profile  Nathaniel Brown Twitter Account  Nathaniel Brown News  Nathaniel Brown on Facebook
Chief Scientific Officer
Richard Colonno
  Richard Colonno LinkedIn Profile  Richard Colonno Twitter Account  Richard Colonno News  Richard Colonno on Facebook
VP - Regulatory Affairs
Eric Ruby
  Eric Ruby LinkedIn Profile  Eric Ruby Twitter Account  Eric Ruby News  Eric Ruby on Facebook

 

 

Browse more venture capital transactions:

Prev: 8/29/2007: Grocery Shopping Network venture capital transaction
Next: 8/29/2007: MeetingSense Software venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.